Workforce shifts and clinical trial diversity reshape corporate strategies by 2027

A growing skills gap and shifting workforce demographics are pushing companies to rethink leadership development and clinical trial practices. With millions of experienced employees nearing retirement, businesses face the risk of losing critical knowledge unless they adopt structured succession plans. At the same time, regulators and communities are demanding greater diversity in clinical research to better reflect real-world populations.

Over 4 million Baby Boomers in the US alone will reach retirement age each year until at least 2027. This wave of departures could remove up to 10% of some workforces within five years, including many senior leaders with decades of expertise. Yet 56% of US employers lack a formal succession plan, leaving them vulnerable to leadership shortages.

To address this, experts recommend intentional talent development that goes beyond informal networks. Structured upskilling and reskilling programmes are now essential, particularly for Gen Z and early-career employees who need accelerated knowledge transfer. Inclusive practices must also expand to marginalised groups, moving away from relying solely on 'known quantities' for leadership roles.

Meanwhile, the biopharmaceutical industry faces its own inclusion challenge. Regulators like the FDA and EMA increasingly expect clinical trials to represent diverse populations. Companies that redesign trials to remove participation barriers—such as location, language, or access—can build trust and gain a competitive edge. For example, Sanofi and Teva Pharmaceuticals advanced a Phase 2b Crohn's disease trial in 2023, while Verily and the Crohn's & Colitis Foundation expanded a research registry in 2022. However, details on how these efforts measure representation success remain unclear. The next five years will test how well organisations adapt to demographic and regulatory changes. Those that implement inclusive succession planning and clinical trial design stand to retain critical skills and strengthen community trust. Without action, businesses risk widening gaps in leadership and research that could take years to recover from.